Globe Life
GL
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
1
In their latest 13F (Q3 2026)
See who
Value held
$4.0m
Combined value at quarter end
Last quarter
0 bought
1 sold or trimmed
Price at Q2 ’26 end
$178.68
+27.8% in the quarter
Share price change by quarter
+5.3%Q4 ’24
+18.1%Q1 ’25
-5.6%Q2 ’25
+15.0%Q3 ’25
-2.2%Q4 ’25
0.0%Q1 ’26
+27.8%Q2 ’26
Managers holding it, by quarter
0Q4 ’23
0Q1 ’24
0Q2 ’24
1Q3 ’24
1Q4 ’24
1Q1 ’25
1Q2 ’25
1Q3 ’25
1Q4 ’25
1Q1 ’26
1Q2 ’26
0Q3 ’26
Who holds it
| Tweedy, Browne | 0.3%$4.0m | Trimmed -20% |
Directors buying and selling
How this works
| Bought or sold | ||||
|---|---|---|---|---|
| 22 Sep 2026 | Hensley Robert EdwardEVP & Chief Investment Officer | ▼ Sold | 6,656 | $1.1m |
| 22 Sep 2026 | Hensley Robert EdwardEVP & Chief Investment Officer | ▼ Sold | 3,344 | $567k |
| 7 Aug 2026 | Mitchell Robert BrianEVP, General Counsel and CRO | ▼ Sold | 11,454 | $2.1m |
| 7 Aug 2026 | Mitchell Robert BrianEVP, General Counsel and CRO | ▼ Sold | 10,529 | $1.9m |
| 7 Aug 2026 | Mitchell Robert BrianEVP, General Counsel and CRO | ▼ Sold | 1,017 | $188k |
| 31 Jul 2026 | Darden James MatthewCo-Chairman & CEO | ▼ Sold | 49,600 | $9.0m |
| 31 Jul 2026 | Darden James MatthewCo-Chairman & CEO | ▼ Sold | 400 | $73k |
| 30 Jul 2026 | Kalmbach Thomas PeterEVP & CFO | ▼ Sold | 10,720 | $1.9m |
| 30 Jul 2026 | Kalmbach Thomas PeterEVP & CFO | ▼ Sold | 4,840 | $872k |
| 30 Jul 2026 | Kalmbach Thomas PeterEVP & CFO | ▼ Sold | 2,790 | $507k |
| 30 Jul 2026 | Kalmbach Thomas PeterEVP & CFO | ▼ Sold | 2,650 | $480k |
| 29 Jul 2026 | Majors Michael ClayEVP - Chief Strategy Officer | ▼ Sold | 33,500 | $6.0m |
| 29 Jul 2026 | Majors Michael ClayEVP - Chief Strategy Officer | ▼ Sold | 3,500 | $628k |
| 28 Jul 2026 | Kalmbach Thomas PeterEVP & CFO | ▼ Sold | 12,303 | $2.2m |
| 28 Jul 2026 | Kalmbach Thomas PeterEVP & CFO | ▼ Sold | 9,550 | $1.7m |
| 28 Jul 2026 | Kalmbach Thomas PeterEVP & CFO | ▼ Sold | 3,797 | $681k |
About the company
- Sector
- Insurance · Life Insurance
- Incorporated in
- Delaware
- Financial year ends
- 31 December
- Shares outstanding
- 77m at 31 Jul 2026
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
$3.5bn2013
$3.8bn2015
$4.2bn2017
$4.5bn2019
$5.1bn2021
$5.4bn2023
$6.0bn2025
| Year | Revenue | Net income |
|---|---|---|
| 2025 | $6.0bn | $1.2bn |
| 2024 | $5.8bn | $1.1bn |
| 2023 | $5.4bn | $971m |
| 2022 | $5.2bn | $894m |
| 2021 | $5.1bn | $1.0bn |
| 2020 | $4.7bn | $732m |
| 2019 | $4.5bn | $761m |
| 2018 | $4.3bn | $701m |
| 2017 | $4.2bn | $1.5bn |
| 2016 | $3.9bn | $550m |
| 2015 | $3.8bn | $527m |
| 2014 | $3.6bn | $543m |
| 2013 | $3.5bn | $528m |